PMID: Clin Vaccine Immunol. 2015 Feb ;22(2):229-34. Epub 2014 Dec 24. PMID: 25540271 Abstract Title: Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Abstract: Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospitalization. Therefore, influenza and pneumococcal vaccinations are strongly recommended for …
Author Archives: Taylor Mercado
There is too large of a gap in knowledge to adequately model herd and serotype replacement effects to reliably predict the population impact of PCVs.
PMID: Vaccine. 2015 Mar 30 ;33(14):1633-58. Epub 2015 Feb 11. PMID: 25681663 Abstract Title: Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014). Abstract: BACKGROUND: Seven-valent pneumococcal conjugate vaccines (PCV7) have been used in children for more than a decade. Given the observed increase in disease caused …
The most common adverse events following adenovirus vaccine were Guillain Barre syndrome and anaphylaxis.
n/a PMID: Vaccine. 2019 Oct 16 ;37(44):6760-6767. Epub 2019 Sep 20. PMID: 31548014 Abstract Title: Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018. Abstract: BACKGROUND: In March 2011, the U.S. Food and Drug Administration licensed adenovirus type 4 …
Some studies suggesting adverse events are not related to anthrax receipt may have too short of a follow-up period to rule out complex or delayed adverse events.
PMID: Arch Neurol. 2007 Mar ;64(3):457-8; author reply 458. PMID: 17353397 Abstract Title: Adverse reactions to anthrax vaccine (eg, optic neuritis) may be more complex or delayed than reported initially by Payne et al (2006). Abstract: [n/a] read more
There are significant unanswered questions and ethical issues with anthrax research.
PMID: J Med Ethics. 2009 Oct ;35(10):594-8. PMID: 19793937 Abstract Title: Unanswered questions and ethical issues concerning US biodefence research. Abstract: Unanswered questions and ethical issues associated with US biodefence medical research over the past five decades are discussed. Objective scientific standards are essential for making policy decisions that can stand the test of time. …
Vaccination against anthrax was four times more likely among disabled Veterans with hostile fire pay records.
PMID: Vaccine. 2012 Sep 21 ;30(43):6150-6. Epub 2012 Aug 5. PMID: 22874851 Abstract Title: Disability among US Army Veterans vaccinated against anthrax. Abstract: CONTEXT: To protect troops against the use of anthrax as a biological weapon, the US Department of Defense began an anthrax vaccination program in 1998. 14 years after the inception of the …
Females are signficantly more likely to experience an adverse event in association with the anthrax vaccine.
PMID: Vaccine. 2014 Jun 12 ;32(28):3548-54. Epub 2014 Apr 24. PMID: 24768633 Abstract Title: Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) Abstract: BACKGROUND: Anthrax vaccine adsorbed (AVA) administered intramuscularly (IM) results in fewer …
This paper details the poor handling of anthrax and smallpox viruses by the CDC.
PMID: Lancet. 2014 Jul 26 ;384(9940):294. PMID: 25072062 Abstract Title: Anthrax and smallpox errors highlight gaps in US biosafety. Abstract: [n/a] read more
Vaccines can now be licensed using only animal safety studies.
PMID: NPJ Vaccines. 2016 ;1:16013. Epub 2016 Aug 25. PMID: 29263855 Abstract Title: First vaccine approval under the FDA Animal Rule. Abstract: The US Food and Drug Administration's Animal Rule was established to facilitate licensure of new products for life-threatening conditions when traditional efficacy trials in humans are unethical or impractical. In November, 2015 BioThrax …
Continue reading “Vaccines can now be licensed using only animal safety studies.”
Isoquercitrin may be considered a safer alternative for managing osteoporosis.
PMID: Eur J Pharmacol. 2019 Dec 15 ;865:172785. Epub 2019 Nov 9. PMID: 31712059 Abstract Title: Antiosteoporotic activities of isoquercitrin in ovariectomized rats: Role of inhibiting hypoxia inducible factor-1 alpha. Abstract: Postmenopausal osteoporosis is a common and disabling disorder that increases the risk of bone fractures due to estrogen deprivation; this can be simulated in …
Continue reading “Isoquercitrin may be considered a safer alternative for managing osteoporosis.”
Health Time 